An interesting correspondence article was published by The Lancet from the University of Erlangen–Nuremberg in Germany in collaboration with the Bavarian Cancer Research Center (BZKF). This article discusses the CAR…
CAR T
-
-
Some of the most significant current research needs to focus on how to best utilize the new medicines for cancer when they become available in order to maximize the number…
-
The novel kind of cancer immunotherapy known as chimeric antigen receptor (CAR) T-cell treatment has prompted the US Food and Drug Administration (FDA) to announce an investigation into the potential…